Never Give Up – Two Decades of Struggles From Diagnosing Their Children to Starting a Clinical Trial For Aspartylglucosaminuria with Rare Mom Julia Taravella
ONCE UPON A GENE – EPISODE 171
Never Give Up – Two Decades of Struggles From Diagnosing Their Children to Starting a Clinical Trial For Aspartylglucosaminuria with Rare Mom Julia Taravella
Julia Taravella is a mom to two adult children, Alexander and Daniel, and she’s the founder of the Rare Trait Hope Fund. Julia’s sons didn’t have a diagnosis for 16 years until she went above and beyond to seek out answers and use the genetic data available to her to reveal a diagnosis of Aspartylglucosaminuria (AGU), a rare, fatal, lysosomal storage disorder.
EPISODE HIGHLIGHTS
Can you tell us about your sons and their diagnosis journey?
Alexander and Daniel are 22 and 27. In kindergarten and first grade, Daniel was doing below average. Daniel was 5 years old when his brother Alexander was born. Alexander started early intervention, but started to have the same delays as Daniel. Having two children presenting the same developmental delays, I suspected it was genetic, but it was difficult to get genetic testing at that time. I sought consultations with physicians and specialists, the boys underwent testing, and all results revealed they were within the expected range. A direct-to-consumer genetic test came out on the market and I bought two of them for my husband and I, figuring there may be something uncovered through our DNA. We went on to test both kids and close relatives too and the results were inconclusive. I dug deeper by downloading all of the data from the testing website and went back to doctors with it, but I wasn’t taken seriously. I found a person in bioinformatics who agreed to analyze and clean up the data. When the data was returned, I took genetics classes for 6 months, wrote a program to analyze the data and determined my sons had AGU. The diagnosis was confirmed by doctors through further blood and urine testing.
What did you do after getting a diagnosis?
I attended a conference and connected with new families with other glycoprotein lysosomal diseases and it helped to meet them. I had hope that something could be done and I frantically started writing emails to anyone I could find in the published AGU literature. I wrote about 200 emails and through those emails I connected with a Finnish doctor who invited me to go to Finland to meet with her. We stopped in Germany on the way and connected with a biochemist to discuss potential treatment options.
What should everyone watch out for when developing gene therapy programs?
It’s important to have a signed sponsorship agreement about how research and funding is handled without knowing what you’ll get in return. Take small steps and don’t invest everything you’ve raised at once to test if you’ll receive the results you want within the time frame you’ve set. Step-by-step developments will help develop a rapport with your researcher to develop trust and gain understanding about where funding goes. Also be sure to understand who is working on what and maintain open lines of communication with everyone.
LINKS & RESOURCES MENTIONED
https://effieparks.com/podcast/episode-154-terry-pirovolakis-groundbreaking-gene-therapy
CONNECT WITH EFFIE PARKS
https://twitter.com/OnceUponAGene
https://www.instagram.com/onceuponagene.podcast/?hl=en
Built Ford Tough Facebook Group
https://www.facebook.com/groups/1877643259173346/
Interested in advertising on Once Upon a Gene? Email [email protected] for more information!
